632
Views
33
CrossRef citations to date
0
Altmetric
Review

Anxiety, depression and sleep disorders in patients with diabetic neuropathic pain: a systematic review

, , ORCID Icon, , & ORCID Icon
Pages 1201-1209 | Received 23 May 2019, Accepted 06 Aug 2019, Published online: 14 Aug 2019

References

  • World Health Organization. Word diabetes report. Guidance summary on globally updated data about diabetes mellitus. 2016.
  • Selvarajah D, Cash T, Sankar A, et al. The contributors of emotional distress in painful diabetic neuropathy. Diabetes Vasc Dis Res. 2014;11:218–225.
  • Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35:206–213.
  • Jain R, Jain S, Raison CL, et al. Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators. Curr Diab Rep. 2011;11:275–284.
  • Bouhassira D, Letanoux M, Hartemann A. Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study. PLoS One. 2013;8:1–9.
  • Hessler D, Fisher L, Strycker LA, et al. Causal and bidirectional linkages over time between depression and diabetes regimen distress in adults with type 2 diabetes. Diabetes Res Clin Pract. 2015;108:360–366.
  • Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3:461–471.
  • Senba E. A key to dissect the triad of insomnia, chronic pain, and depression. Neurosci Lett. 2015;589:197–199.
  • Allen KD, Renner JB, Devellis B, et al. Osteoarthritis and sleep: the Johnston County osteoarthritis project KELLI. J Rheumatol. 2016;35:1102–1107.
  • Alsaadi SM, McAuley JH, Hush JM, et al. Prevalence of sleep disturbance in patients with low back pain. Eur Spine J. 2011;20:737–743.
  • Belt NK, Kronholm E, Kauppi MJ. Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol. 2009;27:35–41.
  • Roth T, Krystal A, Lieberman III J. Long-term issues in the treatment of sleep disorders. Prim Psychiatry. 2007;14:1–14.
  • O’Brien EM, Waxenberg LB, Atchison JW, et al. Negative mood mediates the effect of poor sleep on pain among chronic pain patients. Clin J Pain. [Internet]. 2010;26:310–319. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20393266
  • Smith M, Wickwire E, Grace E, et al. Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep. 2009;32:779–790.
  • Taylor-stokes G, Pike J. Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2011;4:401–408.
  • Higgins JPT, Green S. Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. 2011. Available from: http://www.cochrane.es/?q=es/node/269.
  • Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:1623–1627.
  • Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30:374–385.
  • Sadosky A, Schaefer C, Mann R, et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes, Metab Syndr Obes Targets Ther. 2013;6:79–92.
  • Anderson SG, Narayanan RP, Malipatil NS, et al. Socioeconomic deprivation independently predicts painful diabetic neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2015;123:423–427.
  • Ritzwoller DP, Ellis JL, Korner EJ, et al. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin. 2009;25:1319–1328.
  • Ziegler D, Schneider E, Boess FG, et al. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice. J Diabetes Complications. 2014;28:698–704.
  • D’Amato C, Morganti R, Greco C, et al. Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities. Diabetes Vasc Dis Res. 2016;13:418–428.
  • Demir AB, Kotan Z, Kotan VO. Pain, daytime sleepiness, anxiety and depression levels of patients with chronic neuropathic pain syndromes. J Neurol Sci. 2016;47:89–101.
  • Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain. 2006;22:681–685.
  • Johnston SS, Udall M, Alvir J, et al. Characteristics, treatment, and health care expenditures of medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia. Pain Med. 2014;15:562–576.
  • Dermanovic Dobrota V, Hrabac P, Skegro D, et al. The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes. Health Qual Life Outcomes. 2014;12:171.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.